Metsera, Inc. (MTSR): Nilai Total Aset Perusahaan

Logo grafis Metsera Corp (MTSR)

Metsera Inc (MTSR) is developing long-acting peptide anti-obesity treatments to ensure stable earnings protected by patents. The company's aggregate resources on the GURU.Markets time chart confirm this foundation, where 0.00 determines the latest valuation metric. However, geopolitical tensions are slowing global trials and biomaterial deliveries while production facilities undergo scheduled modernization to meet international quality standards.

Total Aset Perusahaan Metsera Inc (MTSR): kanggo periode 01.02.2025 - 29.11.2025

Rincian metrik komprehensif lan analitis Metsera Corp (MTSR)

- rega lan prakiraan konsensus rega:
Bagan owah-owahan rega metsera.com|MTSR - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Metsera Therapeutics|MTSR - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham Metsera|MTSR - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku metsera.com|MTSR - Aset Agregat Perusahaan
- data utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Metsera Inc|MTSR - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Metsera Therapeutics|MTSR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Metsera Therapeutics
Pambiji fundamental:MTSR, metsera.com
Produk dadi Metsera Inc

Metsera Inc (MTSR) leverages the strong scientific expertise of its leadership to expand within the metabolic drug segment. Asset dynamics (equity + liabilities), reverse-calculated via ROA, reflect the total volume of resources and leverage, allowing investors to assess capital management efficiency and the pace of material base expansion to execute the long-term development strategy of the biotech portfolio.

Pesaing Metsera Inc (MTSR)

ASND (ascendispharma.com) - Nilai Agregat Aset|Aset Agregat Perusahaan Madrigal Pharmaceuticals, Inc. MDGL|Nilai Total Aset Perusahaan Corcept Therapeutics Inc.|Rhythm Pharmaceuticals Inc (RYTM) - Total Aset Perusahaan|Nilai Agregat Aset Akero Corp (AKRO)|Total Aset Perusahaan MLTX (MoonLake Immunotherapeutics)|crinetics.com - Total Aset Perusahaan|Aset Agregat Perusahaan NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Nilai Agregat Aset|FOLD (Amicus Pharma) - Aset Agregat Perusahaan|89bio Pharma (ETNB) - Gunggung Aset Perusahaan|AGIO (Agios Pharmaceuticals) - Total Aset Perusahaan|Total Aset Perusahaan structuretx.com (GPCR)|MiMedx (MDXG) - Gunggung Aset Perusahaan|Nilai Agregat Aset RZLT (Rezolute Inc)|Lexicon Pharma - Aset Agregat Perusahaan|Gunggung Aset Perusahaan MBX Corp MBX|ALT (Altimmune, Inc.) - Total Aset Perusahaan|aardvarktherapeutics.com (AARD) - Aset Perusahaan|SGMT - Gunggung Aset Perusahaan|BioAge Labs (BIOA) - Aset Agregat Bisnis|BMEA (Biomea) - Total Aset Perusahaan|Total Aset Perusahaan Quince|Total Aset Perusahaan Fractyl Health, Inc. (GUTS)|Aset Agregat Perusahaan VTVT (vtvtherapeutics.com)|ATPC: Aset Agregat Perusahaan|Pluristem Therapeutics - Aset Perusahaan|SYBX - Aset Agregat Perusahaan|LPCN - Aset Agregat Perusahaan|matinasbiopharma.com - Total Aset Perusahaan|SPRB (sprucebiosciences.com) - Gunggung Aset Perusahaan|GLTO: Aset Agregat Perusahaan|Gunggung Aset Perusahaan CTCX|Aset Agregat Perusahaan LUMO (Lumos Pharma Corp)|Gunggung Aset Perusahaan ONVO (Organovo Corp)|Radius Recycling, Inc. - Aset Agregat Perusahaan